James R. Heath, PhD, President of the Institute for Systems Biology will discuss key single-cell learnings and applications from the large Seattle-based academic pharmaceutical consortium committed to defining molecular mechanisms of SARS-CoV-2 infection and identifying potential prognostic immune biomarkers. Stacey Willard, PhD, from IsoPlexis will discuss how functional phenotyping individual immune cells using IsoPlexis technology edges researchers closer to predicting the risk for severe disease. 

The use of yeast artificial chromosomes has enabled the rapid genetic reconstruction of the novel coronavirus.

The Johns Hopkins University professor was a co-developer of the Galaxy platform, an open-source bioinformatics tool used in labs around the world.

Researchers find 380 amino acid substitutions between 2019-nCoV and severe acute respiratory syndrome (SARS)-related coronaviruses.

An interrogation of the whole genomes of more than 2,600 cancers yields clues about the genetic drivers of malignancy, how tumors evolve, and more.

Researchers determined that the incidence of new genetic mutations is comparable in people of different ancestries, but lower in Amish people.

The Stanford University researcher’s groundbreaking work connected the fields of molecular biology and genetics, paving the way for the founding of genomics.

The DNA-protein complex has branches that fold back on themselves.

The authors say their results demonstrate the global benefits of studying African genetics.